针对骨导向疗法的潜在准机制
Betul Celik1,2, Andrés Felipe Leal2,3, Shunji Tomatsu2,4,5
1Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.
International journal of molecular sciences
|August 10, 2024
概括
针对骨发育的向药物输送面临着由于无血管性的挑战. 需要新的策略来提高特异性,降低免疫性,提高循环,以有效治疗骨.
科学领域:
- 生物医学工程 生物医学工程
- 骨生物学 骨生物学
- 药物输送系统 药物输送系统
背景情况:
- 骨发育涉及复杂的途径,失调导致骨疾病.
- 与软组织相比,骨和软骨的无血管性质使药物输送复杂化.
- 现有的治疗方法,如酶注入,激素疗法,基因和细胞疗法提供部分改善,但有局限性.
研究的目的:
- 综合审查目前用于药物输送的骨定位策略.
- 突出现有骨治疗方法的挑战和局限性.
- 强调加强骨准系统的未来方向.
主要方法:
- 关于骨定位策略的当前文献的综述.
- 分析骨结构和重塑概念.
- 探索新的传递方法和受体调节的途径.
主要成果:
- 目前的骨准方法有希望,但不能完全纠正骨功能障碍,特别是生长板的问题.
- 新的输送方法需要提高目标特异性,降低免疫原性和延长循环.
- 使用有机和无机化合物的向药物输送是一种有希望的临床前方法.
结论:
- 对于有效的骨治疗,需要在骨向药物输送方面取得重大进展.
- 未来的策略应侧重于增强特异性,最大限度地减少免疫反应,改善药物持续性.
- 有针对性的输送系统有可能用于治疗骨疾病的临床转化.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K


